300147 香雪制药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-11.995-18.384-20.184-21.3312.069
总资产报酬率 ROA (%)-2.667-4.597-5.295-5.9410.704
投入资产回报率 ROIC (%)-4.822-7.820-8.881-9.3841.017

边际利润分析
销售毛利率 (%)31.10034.34824.86926.27732.309
营业利润率 (%)-10.191-14.470-21.222-19.3666.573
息税前利润/营业总收入 (%)-0.462-6.414-13.687-14.1259.145
净利润/营业总收入 (%)-12.839-17.473-23.074-21.7743.765

收益指标分析
经营活动净收益/利润总额(%)105.54839.38575.91831.632120.697
价值变动净收益/利润总额(%)-7.75812.318-9.244-7.91114.861
营业外收支净额/利润总额(%)16.79614.4589.3237.563-45.459

偿债能力分析
流动比率 (X)0.3600.3530.3240.4860.593
速动比率 (X)0.2790.2740.2340.3660.470
资产负债率 (%)73.71972.06568.52665.79465.782
带息债务/全部投入资本 (%)55.92153.75551.03254.57052.751
股东权益/带息债务 (%)70.46876.14986.17079.09284.716
股东权益/负债合计 (%)28.74732.25438.95340.44044.011
利息保障倍数 (X)-0.039-0.611-1.409-2.0701.977

营运能力分析
应收账款周转天数 (天)137.020102.156139.642129.415116.388
存货周转天数 (天)106.336104.740134.579131.612138.166